Director Ray Aspiri just bought 40,000 OMER shares on the open market at an average of $5.72/share.
good volume and up nicely today. the selloff late 2012 was way overdone
question is are they trying to increase the share price for a possible dilution?
why would a director spend a quarter million if he felt the share price wasn't a value.... he can't prop the share price with such a purchase....OMER has a smaller market cap than many private bio's that are much further from potential revenue